CERo Therapeutics Names Andrew Kucharchuk CFO, Kristen Pierce Chief Development Officer-March 2024-www.financetom.com

CERo Therapeutics Names Andrew Kucharchuk CFO, Kristen Pierce Chief Development Officer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

CERo Therapeutics Names Andrew Kucharchuk CFO, Kristen Pierce Chief Development Officer

Oct 2, 2024 11:06 PM

10:42 AM EDT, 10/02/2024 (MT Newswires) -- CERo Therapeutics ( CERO ) said Wednesday that Andrew Kucharchuk has been named chief financial officer.

Kucharchuk previously served as CFO of both Nukkelous and Chain Bridge I, the company said.

CERo also named Kristen Pierce chief development officer. Pierce was previously vice president of translational medicine at Pionyr Therapeutics, CERo said.

Price: 0.09, Change: -0.01, Percent Change: -9.36

Previous page： High Tide to Raise 15 Million Canadian Dollars in Subordinated Debt Next page： EPAM Systems Acquires Odysseus Data Services

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

High Tide to Raise 15 Million Canadian Dollars in Subordinated Debt

Jun 13, 2024

10:29 AM EDT, 06/13/2024 (MT Newswires) -- High Tide (HITI) said Thursday that it will raise 15 million Canadian dollars ($10.9 million) in subordinated debt financing under binding subscription agreements with arm's length institutional credit providers. Under the financing, the company will complete an offering of CA$1,000 principal subordinate secured debentures at $900 per debenture, representing a 10% original issue...

EPAM Systems Acquires Odysseus Data Services

Jun 13, 2024

10:29 AM EDT, 06/13/2024 (MT Newswires) -- EPAM Systems ( EPAM ) said Thursday it acquired health data analytics company Odysseus Data Services. Financial terms of the transaction were not disclosed. EPAM ( EPAM ) said the acquisition will support its life sciences value chain. Price: 180.97, Change: +0.92, Percent Change: +0.51 ...

Cheetah Net Supply Chain Service Insider Sold Shares Worth $1,286,594, According to a Recent SEC Filing

Jun 13, 2024

10:28 AM EDT, 06/13/2024 (MT Newswires) -- Huoyuan Chen, 10% Owner, on April 19, 2024, sold 1,000,000 shares in Cheetah Net Supply Chain Service ( CTNT ) for $1,286,594. SEC Filing: https://www.sec.gov/Archives/edgar/data/1951667/000110465924071119/xslF345X03/tm2417110-1_4seq1.xml Price: 0.53, Change: -0.01, Percent Change: -1.11 ...

J.P. Morgan Life Sciences Private Capital's Biotechnology Venture Capital Fund Closes Above $500 Million Target

Jun 13, 2024

10:29 AM EDT, 06/13/2024 (MT Newswires) -- JPMorgan Chase's ( JPM ) J.P. Morgan Life Sciences Private Capital said Thursday its first biotechnology venture capital fund closed above its $500 million target. The 270 Life Sciences Private Capital Fund I investment vehicle invests in private biotechnology companies and its portfolio investments span cardiometabolic disease, oncology, immunology and genetic medicines, the...